Cartalax (20 mg)
$60.00
- Amino Acid Sequence
- Ala-Glu-Asp (AED)
- Molecular Formula
- C₁2H19N3O8
- Molecular Weight
- 333.29 g/mol
- PubChem CID
- 87815447
- Synonyms
- T-31, AED, SCHEMBL5324601, Alanyl-glutamyl-aspartic acid
For laboratory research use only. Not for human use.
- Lyophilized peptides should be reconstituted using proper aseptic laboratory technique.
- Reconstitution must be performed using Canlab-supplied Bacteriostatic Water and handled in accordance with generally accepted research practices.
- Warranty related to reconstitution, sterility or material integrity applies only when Canlab Bacteriostatic Water is used.
- Use of third-party diluents or deviation from the provided handling guidance voids any applicable warranty.
For full handling instructions and limitations, see the Peptide Reconstitution, Research Use Only section in our Product Warranty Policy Page →
Description
Cartalax, a concise peptide possessing bioregulatory characteristics, primarily influences fibroblasts, pervasive cells present in diverse tissues ranging from cartilage to skin, blood vessels, and the kidneys. Studies suggest that Cartalax modulates cell proliferation and apoptosis via multiple molecular pathways, such as elevating Ki-67 levels, diminishing p53 signaling, and triggering NF-KB signaling. Categorized as an anti-aging bioregulator, Cartalax diminishes senescence, rejuvenates older cells, and seemingly decelerates the general aging process within tissues.
Additional Information
Benefits
Please review the complete product description and available supporting documentation for product-specific research information. This product is sold strictly for laboratory research use.
Mechanism of Action
Refer to the product description, certificate of analysis and applicable published research for product-specific information. No medical or therapeutic claims are made.
